Inter Parfums (IPAR) Q4 Earnings: What To Expect

Adam Hejl /
2024/02/26 2:02 am EST

Fragrance and perfume company Inter Parfums (NASDAQ:IPAR) will be reporting results tomorrow after the bell. Here's what to look for.

Last quarter Inter Parfums reported revenues of $368 million, up 31.2% year on year, beating analyst revenue expectations by 3.8%. It was a solid quarter for the company, with an impressive beat of analysts' earnings estimates. On the other hand, its full-year revenue guidance slightly missed Wall Street's estimates (although EPS guidance for the full year was raised and outperformed expectations).

Is Inter Parfums buy or sell heading into the earnings? Read our full analysis here, it's free.

This quarter analysts are expecting Inter Parfums's revenue to grow 4.2% year on year to $323.8 million, slowing down from the 47.5% year-over-year increase in revenue the company had recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.33 per share.

Inter Parfums Total Revenue

Majority of analysts covering the company have reconfirmed their estimates over the last thirty days, suggesting they are expecting the business to stay the course heading into the earnings. The company only missed Wall St's revenue estimates once over the last two years, and has on average exceeded top line expectations by 6.7%.

Looking at Inter Parfums's peers in the personal care segment, some of them have already reported Q4 earnings results, giving us a hint of what we can expect. USANA's revenues decreased 3% year on year, beating analyst estimates by 4.1% and Nu Skin reported revenue decline of 6.5% year on year, exceeding estimates by 2.6%. USANA traded flat on the results, and Nu Skin was down 12.6%.

Read our full analysis of USANA's results here and Nu Skin's results here.

Investors in the personal care segment have had steady hands going into the earnings, with the stocks down on average 0.4% over the last month. Inter Parfums is up 9.6% during the same time, and is heading into the earnings with analyst price target of $170.7, compared to share price of $152.2.

When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we’ve found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback.